Enzo Biochem Inc. (ENZ)
Medical biotechnology is the use of living cells and cell materials to research and produce pharmaceutical and diagnostic products that help treat and prevent human diseases. Most medical biotechnologists work in academic or industrial settings. In academic laboratories, these professionals conduct experiments as part of medical research studies; industrial biotechnologists work toward developing drugs or vaccines. The medical biotechnology field has helped bring to market microbial pesticides, insect-resistant crops, and environmental clean-up techniques.

Examples of discoveries in the field of medical biotechnology include insulin and growth hormone. Both discoveries were the result of research studies related to deoxyribonucleic acid (DNA). Many scientists in the medical biotechnology field study genetic engineering. This involves isolating, identifying, and sequencing the human genes to determine their functions. Work in this arena may possibly lead to cures for certain diseases, such as Parkinson's and Alzheimer's syndrome.

Enzo Biochem, Inc., is a growth-oriented integrated life sciences and biotechnology company focused on harnessing biological process to develop research tools, diagnostics and therapeutics, and serves as a provider of test services, including exotic tests, to the medical community. Since ENZ was founded in 1976, their strategic focus has been on the development of enabling technologies in the life sciences field.

Enzo Biochem Inc. recently announced that it has added four highly experienced executives at its Enzo Life Sciences subsidiary to focus on rapidly evolving new pharmaceutical and clinical applications.

The officers, all filling newly created positions, are Bruce Taillon, PhD, as head of global technology business development, John D'Errico, PhD, to lead the commercial merchandising operations, Kara Cannon, as head of global marketing and Paul Munger, PhD, to lead Global Manufacturing.

Over the past two years, Enzo has been engaged in enhancing the Life Sciences subsidiary's operating performance through added capabilities, greater integration and a more focused product mix. These efforts are all aimed at significantly expanding Enzo's presence and marketing beyond the traditional academic and research laboratory core to greater penetrate the pharmaceutical and clinical customer base with new and cutting edge platform technologies.

For more information please visit: www.enzo.com

**************************

Crown Equity Holdings, Inc. (CRWE)
Voice over Internet Protocol (VoIP) allows you to make voice calls using a broadband Internet connection instead of a phone line. TCP/IP (transmission control protocol Internet protocol) uses a layered approach to networking. When VoIP is the network transport service, UDP is substituted for TCP. UDP (user datagram protocol) is one of the many protocols included in TCP/IP, so VoIP can be made to run on any network type.

Crown Equity Holdings, Inc., together with its digital network, currently provides electronic media services specializing in online publishing, which brings together targeted audiences and advertisers. Crown Equity Holdings Inc. offers internet media-driven advertising services, which covers and connects a range of marketing specialties, as well as search engine optimization for clients interested in online media awareness.





For more read: pennyotcstock.com/?p=17124